Costs of running a universal adolescent hepatitis B vaccination programme

Vaccine

Volumn 23, Issue 48-49, 2005, Pages 5624-5631

  Wallace, L A ^a   Young, D ^b   Brown, A ^b   Cameron, J C ^a   Ahmed, S ^b   Duff, R ^b   Carman, W F ^c   Kitchin, N R E ^d   Nguyen Van Tam, J S ^e   Goldberg, D J ^a  

^a HEALTH PROTECTION SCOTLAND   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^c GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^d Aventis Pasteur MSD   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Adolescent programme; Cost analysis; Hepatitis B vaccine

Indexed keywords

HEPATITIS B VACCINE;

ACCOUNTING; ADOLESCENT; ARTICLE; COST BENEFIT ANALYSIS; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; HEALTH CARE COST; HEPATITIS B; HUMAN; PRIORITY JOURNAL; SCHOOL CHILD; UNITED KINGDOM; VACCINATION;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; COMMUNITY HEALTH SERVICES; COST-BENEFIT ANALYSIS; FEASIBILITY STUDIES; HEALTH POLICY; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; PROGRAM EVALUATION; SCHOOL HEALTH SERVICES;

EID: 27744466295     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.06.034     Document Type: Article

References (16)

1. P. Van Damme, and A. Vorsters Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001 J Med Virol 68 2002 262 264
2. Global progress towards universal childhood hepatitis B vaccination, 2003. Weekly Epidemiological Record 2003;42:366.
3. J.C. Bramley, L.A. Wallace, S. Ahmed, R. Duff, W.F. Carman, and S.O. Cameron Universal hepatitis B vaccination of UK adolescents: a feasibility and acceptability study Commun Dis Public Health 5 2002 318 320
4. L.A. Wallace, J.C. Bramley, S. Ahmed, R. Duff, S.J. Hutchinson, and W.F. Carman Determinants of universal adolescent hepatitis B vaccine uptake Arch Dis Childhood 89 2004 1041 1042
5. P. Mantagni, A.J. Hall, and C.E.M. Normand Hepatitis B vaccination: the cost effectiveness of alternative strategies in England and Wales J Epidemiol Community Health 49 1995 238 244
6. P. Fenn, A. Gray, and A. McGuire An economic evaluation of universal vaccination against hepatitis B virus J Infect 32 1996 197 204
7. J.R. Williams, D.J. Nokes, and R.M. Anderson Targeted hepatitis B vaccination - a cost-effective immunisation strategy for the UK? J Epidemiol Commun Health 50 1996 667 673
8. W.J. Edmunds Universal or selective immunisation against hepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies Commun Dis Public Health 1 1998 221 228
9. Personal Social Services Research Unit. Available at: http://www.kent.ac.uk/pssru/PDFfiles/UC2002/Inflation#indices.pdf. Accessed 25th July 2003.
10. S. Dobson, D. Scheifele, and A. Bell Assessment of a universal, school-based hepatits B vaccination program JAMA 274 1995 1209 1213
11. R.R. Deuson, E.J. Hoekstra, R. Sedjo, G. Bakker, P. Melinkovich, and D. Doeke The Denver school-based adolescent hepatitis B vaccination program: a cost analysis with risk simulation Am J Public Health 89 1999 1722 1727
12. M. Guay, A.M. Clouatre, M. Blackburn, G. Baron, P. De Wals, and C. Roy Effectiveness and cost comparison of two strategies for hepatitis B vaccination of schoolchildren Can J Public Health 94 2003 64 67
13. H.S. Margolis, P.J. Coleman, R.E. Brown, E.E. Mast, S.H. Sheingold, and J.A. Arevalo Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations JAMA 274 1995 1201 1208
14. The University of British Columbia, Sauder School of Business, Pacific Exchange Rate. Available at: http://www.pacific.commerce.ubc.ca/xr/data.html. Accessed 25th July 2003.
15. M. Krahn, R. Guasparini, M. Sherman, and A.S. Detsky Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program Am J Public Health 88 1998 1638 1644
16. W.M. Cassidy, B. Watson, V.A. Ioli, K. Williams, S. Bird, and D.J. West A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety and immunologic memory Pediatrics 107 2001 626 631